Captrust Financial Advisors Increases Holdings in Relx Plc (NYSE:RELX)

Captrust Financial Advisors boosted its position in shares of Relx Plc (NYSE:RELX - Free Report) by 9.6% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,209,743 shares of the technology company's stock after purchasing an additional 105,946 shares during the quarter. Captrust Financial Advisors owned about 0.07% of Relx worth $54,947,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Virtu Financial LLC bought a new position in Relx during the 3rd quarter worth about $223,000. Wilmington Savings Fund Society FSB bought a new position in shares of Relx during the third quarter valued at approximately $125,000. Franklin Resources Inc. increased its holdings in shares of Relx by 3.3% in the 3rd quarter. Franklin Resources Inc. now owns 18,429 shares of the technology company's stock valued at $873,000 after acquiring an additional 588 shares during the period. JPMorgan Chase & Co. boosted its position in Relx by 14.6% during the third quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company's stock valued at $39,225,000 after purchasing an additional 104,999 shares in the last quarter. Finally, Versant Capital Management Inc purchased a new position in Relx in the fourth quarter valued at about $31,000. 15.02% of the stock is owned by institutional investors.

Relx Stock Up 0.0 %

Relx stock opened at $55.05 on Tuesday. Relx Plc has a fifty-two week low of $41.94 and a fifty-two week high of $55.21. The company has a market cap of $101.88 billion, a PE ratio of 29.59, a PEG ratio of 2.73 and a beta of 0.86. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The business's 50-day simple moving average is $50.10 and its two-hundred day simple moving average is $48.51.

Relx Increases Dividend

The firm also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be issued a $0.5586 dividend. This represents a yield of 1.6%. The ex-dividend date is Friday, May 9th. This is an increase from Relx's previous semi-annual dividend of $0.23. Relx's dividend payout ratio is 59.68%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on RELX shares. Redburn Atlantic began coverage on shares of Relx in a research report on Wednesday, January 8th. They issued a "buy" rating on the stock. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a research report on Friday, March 14th. The Goldman Sachs Group assumed coverage on Relx in a research note on Wednesday, March 26th. They set a "buy" rating on the stock. StockNews.com downgraded Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. Finally, Morgan Stanley restated an "overweight" rating on shares of Relx in a report on Wednesday, April 16th. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Buy".

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.